Assembly Biosciences, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.46 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2014-11-17
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-09-30 was -$1.29M.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-06-30 was $7.34K, a 98.79% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-03-31 was -$1.18M.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-12-31 was $320.39K, a 398.57% increase year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was -$107.40K, a 146.22% decline from fiscal 2012.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $232.38K, a 88.45% decline from fiscal 2011.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $2.01M.
- Assembly Biosciences, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was -$3.05M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 69 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 72 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 75 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 78 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 81 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 84 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 87 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 90 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 93 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 96 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 99 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | -$1.29M derived: sum of 2 quarters · filed 2014-11-17 | -$2.46M 10-Q · filed 2014-11-17 | -$2.14M derived: sum of 4 quarters · filed 2014-11-17 | ||||||||||||
| 2014-06-30 | $7.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.17M 10-Q · filed 2014-08-14 | -$847.87K derived: sum of 3 quarters · filed 2014-08-14 | -$1.12M derived: sum of 4 quarters · filed 2014-11-17 | ||||||||||||
| 2014-03-31 | -$1.18M 10-Q · filed 2014-05-14 | -$855.21K derived: sum of 2 quarters · filed 2014-05-14 | -$1.12M derived: sum of 3 quarters · filed 2014-11-17 | -$514.19K derived: sum of 4 quarters · filed 2014-11-17 | $1.27M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $320.39K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $52.67K derived: sum of 2 quarters · filed 2014-11-17 | $661.41K derived: sum of 3 quarters · filed 2014-11-17 | -$107.40K 10-K · filed 2014-03-31 | $2.45M 10-K · filed 2014-03-31 | |||||||||||
| 2013-09-30 | -$267.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | $341.02K derived: sum of 2 quarters · filed 2014-11-17 | -$427.80K 10-Q · filed 2014-11-17 | -$363.54K derived: sum of 4 quarters · filed 2014-11-17 | $2.13M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $608.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$160.07K 10-Q · filed 2014-08-14 | -$95.81K derived: sum of 3 quarters · filed 2014-08-14 | -$806.46K derived: sum of 4 quarters · filed 2014-08-14 | $2.40M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | -$768.82K 10-Q · filed 2014-05-14 | -$704.55K derived: sum of 2 quarters · filed 2014-05-14 | -$1.42M derived: sum of 3 quarters · filed 2014-05-14 | -$1.88M derived: sum of 4 quarters · filed 2014-05-14 | $1.79M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $64.26K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$646.38K derived: sum of 2 quarters · filed 2014-03-31 | -$1.11M derived: sum of 3 quarters · filed 2014-03-31 | $232.38K 10-K · filed 2014-03-31 | $2.56M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | -$710.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$1.17M derived: sum of 2 quarters · filed 2013-11-12 | $168.12K 10-Q · filed 2013-11-12 | $1.50M derived: sum of 4 quarters · filed 2013-11-12 | $2.49M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | -$461.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $878.76K 10-Q · filed 2013-08-09 | $2.21M derived: sum of 3 quarters · filed 2013-08-09 | $2.65M derived: sum of 4 quarters · filed 2013-08-09 | $3.20M 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $1.34M 10-Q · filed 2013-05-10 | $2.67M derived: sum of 2 quarters · filed 2013-05-10 | $3.11M derived: sum of 3 quarters · filed 2013-05-10 | $3.54M derived: sum of 4 quarters · filed 2013-05-10 | $3.85M 10-Q · filed 2012-05-09 | |||||||||||
| 2011-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.77M derived: sum of 2 quarters · filed 2013-03-18 | $2.20M derived: sum of 3 quarters · filed 2013-03-18 | $2.01M 10-K · filed 2013-03-18 | $2.33M 10-K · filed 2012-03-14 | |||||||||||
| 2011-09-30 | $438.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $873.01K derived: sum of 2 quarters · filed 2012-11-13 | $683.01K 10-Q · filed 2012-11-13 | -$286.23K derived: sum of 4 quarters · filed 2013-03-18 | $995.91K 10-Q/A · filed 2011-11-18 | |||||||||||
| 2011-06-30 | $434.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $244.02K 10-Q · filed 2012-08-09 | -$725.22K derived: sum of 3 quarters · filed 2013-03-18 | -$1.12M derived: sum of 4 quarters · filed 2013-03-18 | $556.91K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | -$190.00K 10-Q · filed 2012-05-09 | -$1.16M derived: sum of 2 quarters · filed 2013-03-18 | -$1.55M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||
| 2010-12-31 | -$969.24K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | -$1.36M derived: sum of 2 quarters · filed 2013-03-18 | -$3.05M 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | -$393.73K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | -$2.08M 10-Q/A · filed 2011-11-18 | ||||||||||||||
| 2010-06-30 | -$1.69M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2009-12-31 | -$762.77K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |